Literature DB >> 20711586

[R248C FGFR3 mutation. Effect on cell growth, apoptosis and attachment in HaCaT keratinocytes].

C Hafner1, A Hartmann.   

Abstract

Activating FGFR3 mutations have been identified in a variety of benign skin lesions (seborrheic keratosis, epidermal nevus, solar lentigo). However, the functional consequences of these mutations in the human epidermis are unknown. We therefore analyzed functional effects of the common R248C mutation in HaCaT keratinocytes. The cells were stably transduced with the R248C FGFR3 mutation or FGFR3-IIIb wildtype sequence using a retroviral system. The R248C mutant keratinocytes revealed significantly enhanced cell growth compared with wildtype cells after reaching confluence. Likewise, apoptosis and attachment to fibronectin were significantly reduced in mutant cells. In contrast, there was no difference regarding migration and oncogene-induced senescence. Gene expression analysis revealed only a few differentially expressed genes between mutant and wildtype HaCaT keratinocytes. ERK1/2 appear to be involved in the FGFR3-dependent signalling of R248C mutant keratinocytes. Our results indicate that an increased cell number at confluence along with reduced apoptosis may contribute to the growth of benign acanthotic tumors in the human epidermis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20711586     DOI: 10.1007/s00292-010-1332-z

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  24 in total

1.  The power and the promise of oncogene-induced senescence markers.

Authors:  Manuel Collado; Manuel Serrano
Journal:  Nat Rev Cancer       Date:  2006-06       Impact factor: 60.716

Review 2.  Fibroblast growth factor receptor 3 mutations in epidermal nevi and associated low grade bladder tumors.

Authors:  Silvia Hernández; Agustí Toll; Eulàlia Baselga; Adriana Ribé; Javier Azua-Romeo; Ramon M Pujol; Francisco X Real
Journal:  J Invest Dermatol       Date:  2007-01-25       Impact factor: 8.551

Review 3.  Cellular signaling by fibroblast growth factor receptors.

Authors:  V P Eswarakumar; I Lax; J Schlessinger
Journal:  Cytokine Growth Factor Rev       Date:  2005-02-01       Impact factor: 7.638

4.  FGF signaling inhibits chondrocyte proliferation and regulates bone development through the STAT-1 pathway.

Authors:  M Sahni; D C Ambrosetti; A Mansukhani; R Gertner; D Levy; C Basilico
Journal:  Genes Dev       Date:  1999-06-01       Impact factor: 11.361

Review 5.  Senescence in tumours: evidence from mice and humans.

Authors:  Manuel Collado; Manuel Serrano
Journal:  Nat Rev Cancer       Date:  2010-01       Impact factor: 60.716

Review 6.  The molecular and genetic basis of fibroblast growth factor receptor 3 disorders: the achondroplasia family of skeletal dysplasias, Muenke craniosynostosis, and Crouzon syndrome with acanthosis nigricans.

Authors:  Z Vajo; C A Francomano; D J Wilkin
Journal:  Endocr Rev       Date:  2000-02       Impact factor: 19.871

Review 7.  Cell responses to FGFR3 signalling: growth, differentiation and apoptosis.

Authors:  Corine G M L'Hôte; Margaret A Knowles
Journal:  Exp Cell Res       Date:  2004-12-16       Impact factor: 3.905

8.  Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia.

Authors:  M C Naski; Q Wang; J Xu; D M Ornitz
Journal:  Nat Genet       Date:  1996-06       Impact factor: 38.330

9.  Somatic FGFR3 and PIK3CA mutations are present in familial seborrhoeic keratoses.

Authors:  C Hafner; T Vogt; M Landthaler; J Müsebeck
Journal:  Br J Dermatol       Date:  2008-07-01       Impact factor: 9.302

10.  Mutant fibroblast growth factor receptor 3 induces intracellular signaling and cellular transformation in a cell type- and mutation-specific manner.

Authors:  E di Martino; C G L'Hôte; W Kennedy; D C Tomlinson; M A Knowles
Journal:  Oncogene       Date:  2009-09-14       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.